ClinicalTrials.gg
Not yet recruitingNCT07823192Updated Sep 16, 2026

A Randomized Controlled Trial Evaluating the Efficacy of Soaking Endotracheal Tube in Dexamethasone Solution for Prevention of Postoperative Sore Throat After Laparoscopic Cholecystectomy

A Phase 2 interventional study of Steroid Drug and Normal (0.9%) saline in Post Operative Sore Throat, sponsored by KRL Hospital, Islamabad. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by KRL Hospital, Islamabad · Phase 2, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if topical application of dexamethasone will prevent sore throat caused by endotracheal intubation in healthy patients undergoing elective surgery. The main question it aims to answer is:

  • Does soaking the endotracheal tube in steroid solution before intubation lower the incidence of postoperative sore throat? Researcher will compare dexamethasone-soaked endotracheal tube to placebo (normal saline-soaked endotracheal tube) to see if topical steroid application in this way reduces development of sore throat.

Participants will be:

  • Intubated with an endotracheal tube, that was either soaked in normal saline or dexamethasone solution, at induction of general anesthesia prior to undergoing elective cholecystectomy
  • Interviewed by the researcher 24 hours after their surgery to assess if they experienced any throat soreness
02

Conditions studied

  • Post Operative Sore Throat

Keywords

  • post operative sore throat
  • ETT soaking
03

In context

Lead sponsor

KRL Hospital, Islamabad is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing general anesthesia requiring ETT insertion during elective laparoscopic cholecystectomy.
  • \& ASA II patients
  • Patients consenting to be a part of the study

Exclusion criteria

Exclusion Criteria:

  • Patients having diabetes mellitus
  • Patients with suspected or incidental difficult Intubation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Dexamethasone group

    Participants intubated with endotracheal tube soaked in dexamethasone solution

    Drug: Steroid Drug

  • Placebo comparator
    Normal saline group

    Participants intubated with endotracheal tube soaked in normal saline

    Drug: Normal (0.9%) saline

Interventions

06

What researchers measure

Primary outcomes

  1. Incidence of post operative sore throat

    Proportion of patients who develop sore throat after surgery

    Time frame: Within 24 hours of surgery

07

Study locations

1 site
08

References and documents

Publications

  • Lee JH, Kim SB, Lee W, Ki S, Kim MH, Cho K, Lim SH, Lee KM, Choi DN, Oh M. Effects of topical dexamethasone in postoperative sore throat. Korean J Anesthesiol. 2017 Feb;70(1):58-63. doi: 10.4097/kjae.2017.70.1.58. Epub 2016 Nov 25. PubMed 28184268 ↗

Individual participant data

Plan to share: No — Individual participant data will be kept confidential and not shared publicly

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2026
First posted
Sep 16, 2026
StartEst.
Nov 2026
Primary completionEst.
Jan 2027
CompletionEst.
Mar 2027
Last update
Sep 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07823192
Lead sponsor
KRL Hospital, Islamabad
Responsible party
Mariam Niaz (Post Graduate Trainee, KRL Hospital, Islamabad) — Principal investigator
First posted
Sep 16, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jan 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Sep 16, 2026

Study contacts

Mariam Niaz, MBBS
Contact
dr.mariamniaz@gmail.com
+923391715167
Dr Ammar Ali Shah, MBBS DA FCPS MHPE Fellowship
study chair · KRL Hospital, Islamabad

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Therapeutic Steroid Hormone

Start the discussion